G. Walmsley Graham - 12 Sep 2023 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
Director
Signature
/s/ Graham Walmsley
Issuer symbol
OLMA
Transactions as of
12 Sep 2023
Net transactions value
-$17,448,750
Form type
4
Filing time
06 Jun 2024, 17:01:17 UTC
Previous filing
10 Aug 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Sale $10,395,000 -700,000 -50% $14.85 700,761 04 Jun 2024 See note F1
transaction OLMA Common Stock Sale $7,053,750 -475,000 -40% $14.85 708,114 04 Jun 2024 See note F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
F2 The shares are held by Logos Opportunities Fund II LP ("Logos Fund II"). Logos Opportunities GP is the general partner of Logos Fund II and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.